Rosuvastatin 5mg Tablet in PCD pharma franchise in Hyderabad

Rosuvastatin 5mg Tablet in pharmaceutical manufacturing company in Mumbai

Rosuvastatin 5mg Tablet in cholesterol care pharma franchise in Pune

Rosuvastatin 5mg Tablet in pharma suppliers in Delhi

Rosuvastatin 5mg Tablet in pharma export companies in Kolkata
Rosuvastatin 5mg Tablet in pharma franchise opportunities in Bengaluru

Rosuvastatin 5 mg tablet

Composition : Rosuvastatin 5 mg tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*15

Price : ₹1/-

Please Contact For Best Price

Rosuvastatin 20 mg + Ezetimibe 10 mg Tablet is a dual-action lipid-lowering formulation that combines a statin with a cholesterol absorption inhibitor. Rosuvastatin, an HMG-CoA reductase inhibitor, works by reducing cholesterol synthesis in the liver, while Ezetimibe selectively inhibits the absorption of cholesterol from the small intestine. Together, they provide a synergistic effect to effectively lower LDL cholesterol and total cholesterol levels, making it suitable for patients who require intensive lipid control or have not achieved goals with statin monotherapy. This combination supports cardiovascular risk reduction in patients with hyperlipidemia or mixed dyslipidemia.

Read More

About the Product

Rosuvastatin 20 mg + Ezetimibe 10 mg Tablet is a dual-action lipid-lowering formulation that combines a statin with a cholesterol absorption inhibitor. Rosuvastatin, an HMG-CoA reductase inhibitor, works by reducing cholesterol synthesis in the liver, while Ezetimibe selectively inhibits the absorption of cholesterol from the small intestine. Together, they provide a synergistic effect to effectively lower LDL cholesterol and total cholesterol levels, making it suitable for patients who require intensive lipid control or have not achieved goals with statin monotherapy. This combination supports cardiovascular risk reduction in patients with hyperlipidemia or mixed dyslipidemia.

Common side effects may include headache, muscle pain, fatigue, and abdominal discomfort. In rare cases, patients may experience liver enzyme elevation, rhabdomyolysis, or hypersensitivity reactions. Periodic monitoring of liver function and creatine kinase levels is advised, especially in patients with predisposing factors for myopathy.

Indicated for the treatment of primary hyperlipidemia or mixed dyslipidemia in adults as an adjunct to diet. It is particularly beneficial for patients requiring additional LDL cholesterol reduction when lifestyle modifications and statin therapy alone are insufficient. The combination is also used in the management of homozygous familial hypercholesterolemia and to lower the risk of cardiovascular events in high-risk patients.

To be used under the supervision of a registered medical practitioner. Not recommended in patients with active liver disease or unexplained persistent elevations in hepatic transaminases. Caution should be exercised in patients with renal impairment or those on other lipid-lowering agents. Avoid use during pregnancy and lactation.

Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Similar Products